Brief: Lucira Health Inc Provides Statement On Copan’S Recall Of Its FLOQSwabs
08/10/2021 11:02
Oct 8 (Reuters) - Lucira Health Inc LHDX.O :
* LUCIRA™ HEALTH PROVIDES STATEMENT ON COPAN’S RECALL OF ITS
FLOQSWABS
* LUCIRA HEALTH INC - ESTIMATES EXPENSES RELATED TO RECALLED
COPAN
SWABS TO BE BETWEEN $75,000 AND $85,000
* LUCIRA HEALTH INC - INTENDS TO PASS-THROUGH ALL RELATED
EXPENSES, INCLUDING BUT NOT LIMITED TO THIRD PARTY AND LEGAL
COSTS, TO COPAN
* LUCIRA HEALTH INC - RECALLED COPAN SWABS HAD NO IMPACT ON
REVENUE RECORDED DURING DISTRIBUTION PERIOD
Source text for Eikon: ID:nGNX8HwGPC
Further company coverage: LHDX.O
Recent news on Lucira Health
See all newsBrief: Lucira Health Inc Filed Its Amended Chapter 11 Plan Of Liquidation With Bankruptcy Court
Brief: Lucira Health Files Proposed Chapter 11 Plan Of Liquidation
Brief: Bankruptcy Court Approves Lucira Health Assets Sale To Pfizer
Brief: Lucira Health Inc Says On April 6, 2023 Co Held Auction Relating To Disposition Of All Or Substantially All Of Company's Assets
Brief: Lucira Health Announces U.S. Launch Of First & Only At-Home Combination Covid-19 & Flu Test Amidst Sale Process